Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Current Assets (2016 - 2025)

Acro Biomedical (ACBM) has 10 years of Current Assets data on record, last reported at $14098.0 in Q4 2025.

  • For Q4 2025, Current Assets rose 177.74% year-over-year to $14098.0; the TTM value through Dec 2025 reached $14098.0, up 177.74%, while the annual FY2025 figure was $14098.0, 177.74% up from the prior year.
  • Current Assets reached $14098.0 in Q4 2025 per ACBM's latest filing, up from $4323.0 in the prior quarter.
  • Across five years, Current Assets topped out at $920256.0 in Q1 2021 and bottomed at $151.0 in Q1 2024.
  • Average Current Assets over 5 years is $337879.9, with a median of $282893.0 recorded in 2023.
  • Peak YoY movement for Current Assets: crashed 99.98% in 2024, then skyrocketed 4179.27% in 2025.
  • A 5-year view of Current Assets shows it stood at $706415.0 in 2021, then dropped by 6.92% to $657537.0 in 2022, then crashed by 99.75% to $1626.0 in 2023, then skyrocketed by 212.18% to $5076.0 in 2024, then soared by 177.74% to $14098.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $14098.0 in Q4 2025, $4323.0 in Q3 2025, and $39626.0 in Q2 2025.